Research Ethics

The centre for Applied Ethics was created in April 2014 as part of a broad restructuring of ethics services at the MUHC.  The 9 Research Ethics Boards (REBs), as well as research ethics, support services have been part of this exercise.   Changes to the REB structure come into effect April 1, 2015.  These will not affect the general principles of how research involving humans is approved.  However, these changes aim at increasing efficiency while maintaining high-quality review of research.

  • There is one MUHC REB and 5 specialised panels
  • The 5 specialised panels will conduct both Science and Ethics review and will meet twice a month on average;
  • Submission deadlines are abolished;
  • The CAE staff will conduct pre-reviews of all studies to ensure 
    • completeness, 
    • minimal quality of documents submitted and 
    • assess level of risk and initiate delegated review of minimal risk studies (instead of full board reviews).

The MUHC currently has a single REB with 5 specialized panels :

  • PED
  • CT1 (Oncology)
  • CT2
  • CTGQ

5 Panels of the MUHC-REB

Pediatrics (PED):
  • All projects involving minors
Clinical Trials 1 (CT1):
  • Oncology
  • Radiation-oncology
  • ObGyn
  • Urology
  • Palliative care research associated to oncology
Cells, tissues, genetics & qualitative research (CTGQ):
  • Artificial intelligence
  • Genetics
  • Biobanking and registries
  • Research on cells and tissues
  • Experimental  cell therapies
  • Pathology
  • Regenerative medicine
  • Epidemiology 
  • Qualitative research
Neurosciences-Psychiatry (NEUPSY):
All projects in:
  • Neuroscience
  • Psychiatry
  • Psychology
Clinical Trials 2 (CT2):
  • Surgery
  • Cardiology
  • Orthopaedics
  • Endocrinology
  • Anesthesiology
  • Gastroenterology
  • Urology
  • Devices
  • Infectious diseases
  • Chronic illness
  • Respiratory and
  • Transplant

MUHC REB Chair: Marie Hirtle

MUHC - Personne Mandatée: Keith Woolrich



REB Coordination 


Carlo Cicero, Brigitte Pâquet (interim)

Elizabeth Craven


Judith Marcoux, Vincent Lajoie (interim)

Sonia Cantini


Vincent Lajoie

Elizabeth Craven


Bertrand Lebouché, Sonya Page

Sheldon Levy 


Marie Hirtle James Ellasus

Schedule of REB FULLBOARD meetings

For the schedule of REB full board meetings, please see in Nagano. Note that studies that are more than minimal risk are reviewed at the fullboard.

Please enter your study in Nagano as soon as possible to initiate the review process.

See also: